CD4-CD8-T cells contribute to the persistence of viral hepatitis by striking a delicate balance in immune modulation

Cellular Immunology

Volumn 280, Issue 1, 2012, Pages 76-84

  Wang, Xiaojing ^a   Yan, Weiming ^a   Lu, Yulei ^a   Chen, Tao ^a   Sun, Ying ^a   Qin, Xiaomin ^a   Zhang, Jiangguo ^a   Han, Meifang ^a   Guo, Wei ^a   Wang, Hongwu ^a   Wu, Di ^a   Xi, Dong ^a   Luo, Xiaoping ^a   Ning, Qin ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

CD8+ T cells; Double negative T cells (DN T cells); Interferon gamma (IFN ); Interleukin 2 (IL 2); Viral hepatitis

Indexed keywords

FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; INTERLEUKIN 2;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DN T CELL; FLOW CYTOMETRY; IMMUNOMODULATION; MOUSE; MURINE HEPATITIS CORONAVIRUS; MURINE HEPATITIS CORONAVIRUS 3; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SURVIVAL RATE; VIRUS HEPATITIS; VIRUS STRAIN;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD95; APOPTOSIS; CD8-POSITIVE T-LYMPHOCYTES; CORONAVIRUS INFECTIONS; CYTOTOXICITY, IMMUNOLOGIC; DISEASE MODELS, ANIMAL; FAS LIGAND PROTEIN; HEPATITIS, CHRONIC; HEPATITIS, VIRAL, ANIMAL; IMMUNOMODULATION; IMMUNOPHENOTYPING; LIVER; LYMPHOKINES; MICE; MICE, INBRED C3H; MURINE HEPATITIS VIRUS; SPLEEN; T-LYMPHOCYTE SUBSETS;

MURINE HEPATITIS VIRUS; MURINE HEPATITIS VIRUS STRAIN 3; MUS;

EID: 84871409561     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2012.11.010     Document Type: Article

References (46)

1. Lavanchy D., Hepatitis B. Virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J. Viral Hepat. 2004, 11:97-107. PubMed: 14996343.
2. Magiorkinis G., Magiorkinis E., Paraskevis D., Ho S.Y., Shapiro B., Pybus O.G., Allain J.P., Hatzakis A. The global spread of hepatitis C virus 1a and 1b: a phylodynamic and phylogeographic analysis. PLoS Med. 2009, 6:e1000198. PubMed: 20041120.
3. Beasley R.P. B. Hepatitis virus. The major etiology of hepatocellular carcinoma. Cancer 1988, 61:1942-1956. PubMed: 2834034.
4. Yasunari N., Shuichi K. Mechanisms of viral hepatitis induced liver injury. Curr. Mol. Med. 2003, 3:537-544. PubMed: 14527085.
5. Shevach E.M. Regulatory T Cells in autoimmmunity*. Annu. Rev. Immunol. 2000, 18:423-449. PubMed:10837065.
6. Chatenoud L., Salomon B., Bluestone J.A. Suppressor T cells - they're back and critical for regulation of autoimmunity!. Immunol. Rev. 2001, 182:149-163. PubMed:11722631.
7. Zelenika D., Adams E., Humm S., Lin C.Y., Waldmann H., Cobbold S.P. The role of CD4+ T-cell subsets in determining transplantation rejection or tolerance. Immunol. Rev. 2001, 182:164-179. PubMed: 11722632.
8. Read S., Malmstrom V., Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+) CD4(+) regulatory cells that control intestinal inflammation. J. Exp. Med. 2000, 192:295-302. PubMed: 10899916.
9. Shimizu J., Yamazaki S., Takahashi T., Ishida Y., Sakaguchi S. Stimulation of CD25(+) CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 2002, 3:135-142. PubMed: 11812990.
10. Bluestone J.A., Abbas A.K. Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 2003, 3:253-257. PubMed: 12658273.
11. Fontenot J.D., Gavin M.A., Rudensky A.Y. Foxp3 programs the development and function of CD4+ CD25+ regulatory T cells. Nat. Immunol. 2003, 4:330-336. PubMed: 12612578.
12. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061. PubMed: 12522256.
13. Sakaguchi S. Naturally arising Foxp3-expressing CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 2005, 6:345-352. PubMed: 15785760.
14. Gonzalez A., Andre-Schmutz I., Carnaud C., Mathis D., Benoist C. Damage control, rather than unresponsiveness, effected by protective DX5+ T cells in autoimmune diabetes. Nat. Immunol. 2001, 2:1117-1125. PubMed: 11713466.
15. Hayday A.C. [gamma][delta] cells: a right time and a right place for a conserved third way of protection. Annu. Rev. Immunol. 2000, 18:975-1026. PubMed: 10837080.
16. Chen M., Zhang D., Zhen W., Shi Q., Liu Y., Ling N., Peng M., Tang K., Hu P., Hu H., Ren H. Characteristics of circulating T cell receptor gamma-delta T cells from individuals chronically infected with hepatitis B virus (HBV): an association between V(delta)2 subtype and chronic HBV infection. J. Infect. Dis. 2008, 198:1643-1650. PubMed: 18954265.
17. Zhang Z.X., Yang L., Young K.J., DuTemple B., Zhang L. Identification of a previously nknown antigen-specific regulatory T cell and its mechanism of suppression. Nat. Med. 2000, 6:782-789. PubMed: 0888927.
18. Priatel J.J., Utting O., Teh H.S. TCR/self-antigen interactions drive double-negative T cell peripheral expansion and differentiation into suppressor cells. J. Immunol. 2001, 167:6188-6194. PubMed: 1714779.
19. Ford M.S., Young K.J., Gao J., Joe B., Zhang L. Cutting edge: in vivo trogocytosis as a echanism of double negative regulatory T cell-mediated antigen specific suppression. J. Immunol. 2008, 181:2271-2275. PubMed: 18684915.
20. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299(5609):1057-1061. PubMed: 12522256.
21. Stoop J.N., van der Molen R.G., Baan C.C., van der Laan L.J., Kuipers E.J., Kusters J.G., Janssen H.L. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology 2005, 41:771-778. PubMed: 15791617.
22. Xu D., Fu J., Jin L., Zhang H., Zhou C., Zou Z., Zhao J.M., Zhang B., Shi M., Ding X., Tang Z., Fu Y.X., Wang F.S. Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J. Immunol. 2006, 177:739-747. PubMed: 16785573.
23. Cabrera R., Tu Z., Xu Y., Firpi R.J., Rosen H.R., Liu C., Nelson D.R. An immuno-modulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology 2004, 40:1062-1071. PubMed: 15486925.
24. Shalev I., Wong K.M., Foerster K., Zhu Y., Chan C., Maknojia A., Zhang J., Ma X.Z., Yang X.C., Gao J.F., Liu H., Selzner N., Clark D.A., Adeyi O., Phillips M.J., Gorczynski R.R., Grant D., McGilvray I., Levy G. The novel CD4+ CD25+ regulatory T cell effector molecule fibrinogen-like protein 2 contributes to the outcome of murine fulminant viral hepatitis. Hepatology 2009, 49(2):387-397. PubMed: 19085958.
25. Lee B.P., Mansfield E., Hsieh S.C., Hernandez-Boussard T., Chen W., Thomson C.W., Ford M.S., Bosinger S.E., Der S., Zhang Z.X., Zhang M., Kelvin D.J., Sarwal M.M., Zhang L. Expression profiling of murine double-negative regulatory T Cells suggest mechanisms for prolonged cardiac allograft survival. J. Immunol. 2005, 174:4535-4544. PubMed: 15814674.
26. Zhang Z.X., Ma Y., Wang H., He K.M., Garcia B., Madrenas J., Zhong R. Double-negative T cells, activated by xenoantigen, lyse autologous B and T cells using a perforin/granzyme-dependent Fas-Fas ligand-independent pathway. J. Immunol. 2006, 177:6920-6929. PubMed: 17082607.
27. Ma Y., He K.M., Garcia B., Min W., Jevnikar A., Zhang Z.X. Adoptive transfer of double negative T regulatory cells induces B-cell death in vivo and alters rejection pattern of rat-to-mouse heart transplantation. Xenotransplantation 2008, 15:56-63. PubMed: 18333914.
28. Crispín J.C., Oukka M., Bayliss G., Cohen R.A., Van Beek C.A., Stillman I.E., Kyttaris V.C., Juang Y.T., Tsokos G.C. Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J. Immunol. 2008, 181:8761-8766. PubMed:19050297.
29. Duncan B., Nazarov-Stoica C., Surls J., Kehl M., Bona C., Casares S., Brumeanu T.D. Double negative (CD3+ 4-8-) TCR alphabeta splenic cells from young NOD mice provide long-lasting protection against type 1 diabetes. PLoS One 2010, 5(7):e11427. PubMed: 20625402.
30. Milush J.M., Mir K.D., Sundaravaradan V., Gordon S.N., Engram J., Cano C.A., Reeves J.D., Anton E., O'Neill E., Butler E., Hancock K., Cole K.S., Brenchley J.M., Else J.G., Silvestri G., Sodora D.L. Lack of clinical AIDS in SIV-infected sooty mangabeys with significant CD4+ T cell loss is associated with double-negative T cells. J. Clin. Invest. 2011, 121(3):1102-1110. PubMed: 21317533.
31. Antonelli L.R., Dutra W.O., Oliveira R.R., Torres K.C., Guimarães L.H., Bacellar O., Gollob K.J. Disparate immunoregulatory potentials for double-negative (CD4- CD8-) alpha beta and gamma delta T cells from human patients with cutaneous leishmaniasis. Infect. Immun. 2006, 74:6317-6323. PubMed: 16923794.
32. Ning Q., Brown D., Parodo J., Cattral M., Gorczynski R., Cole E., Fung L., Ding J.W., Liu M.F., Rotstein O., Phillips M.J., Levy G. Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response. J. Immunol. 1998, 160:3487-3493. PubMed: 9531310.
33. Knodell R.G., Ishak K.G., Black W.C., Chen T.S., Craig R., Kaplowitz N., Kiernan T.W., Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981, 1:431-435. PubMed: 7308988.
34. Guha C., Mohan S., Roy-Chowdhury N., Roy-Chowdhury J. Cell culture and animal models of viral hepatitis Part I: hepatitis B. Lab. Anim. (NY) 2004, 33(7):37-46. PubMed:15224117.
35. Guha C., Lee S.W., Chowdhury N.R., Chowdhury J.R. Cell culture models and animal models of viral hepatitis Part II: hepatitis C. Lab. Anim. (NY) 2005, 34(2):39-47. PubMed:15685191.
36. Marsden P.A., Ning Q., Fung L.S., Luo X., Chen Y., Mendicino M., Ghanekar A., Scott J.A., Miller T., Chan C.W., Chan M.W., He W., Gorczynski R.M., Grant D.R., Clark D.A., Phillips M.J., Levy G.A. The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis. J. Clin. Invest. 2003, 112:58-66. PubMed: 12840059.
37. Ding J.W., Ning Q., Liu M.F., Lai A., Leibowitz J., Peltekian K.M., Cole E.H., Fung L.S., Holloway C., Marsden P.A., Yeger H., Phillips M.J., Levy G.A. Fuliminant hepatic failure hepatitis virus strain 3 infection: tissue-specific expression of a novel fgl2 prothrombinase. J. Virol. 1997, 71:9223-9230. PubMed: 9371581.
38. Ding J.W., Ning Q., Liu M.F., Lai A., Peltekian K., Fung L., Holloway C., Yeger H., Phillips M.J., Levy G.A. Expression of the fgl2 and its protein product (prothrombinase) in tissues during murine hepatitis virus strain-3(MHV-3) infection. Adv. Exp. Med. Biol. 1998, 440:609-618. PubMed: 9782336.
39. Levy G.A., Liu M., Ding J., Yuwaraj S., Leibowitz J., Marsden P.A., Ning Q., Kovalinka A., Phillips M.J. Molecular and functional analysis of the human prothrombinase gene (HFGL2) and its role in viral hepatitis. Am. J. Pathol. 2000, 156:1217-1225. PubMed: 10751347.
40. Zhu C., Sun Y., Luo X., Yan W., Xi D., Ning Q. Novel mfgl2 antisense plasmid inhibits murine fgl2 expression and ameliorates murine hepatitis virus type 3-induced fulminant hepatitis in BALB/cJ mice. Hum. Gene Ther. 2006, 17:589-600. PubMed: 16776568.
41. Pope M., Marsden P.A., Cole E., Sloan S., Fung L.S., Ning Q., Ding J.W., Leibowitz J.L., Phillips M.J., Levy G.A. Resistance to murine hepatitis virus strain 3 is dependent on production of nitric oxide. J. Virol. 1998, 72:7084-7090. PubMed: 9696801.
42. Levy G.A., Leibowitz J.L., Edgington T.S. Induction of monocyte procoagulant activity by murine hepatitis virus type 3 parallels disease susceptibility in mice. J. Exp. Med. 1981, 154:1150-1163. PubMed:6270227.
43. Eva B., Tobias B., Robert T. Regulatory T cells in viral hepatitis. World J. Gastroenterol. 2007, 13(36):4858-4864. PubMed:17828817.
44. Voelkl S., Gary R., Mackensen A. Characterization of the immunoregulatory function of human TCR-alphabeta+CD4- CD8- double-negative T cells. Eur. J. Immunol. 2011, 41:739-748. PubMed:21287552.
45. Zhang X., Sun S., Hwang I., Tough D.F., Sprent J. Potent and selective stimulation of memory-phenotype CD8+ T-cells in vivo by IL-15. Immunity 1998, 8:591-599. PubMed: 9620680.
46. Tanchot C., Guillaume S., Delon J., Bourgeois C., Franzke A., Sarukhan A., Trautmann A., Rocha B. Modifications of CD8+ T-cell function during in vivo memory or tolerance induction. Immunity 1998, 8:581-590. PubMed: 9620679.